Svedbom, Axel <br/><br/>
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis.  [electronic resource] 

 -  The European journal of health economics : HEPAC : health economics in prevention and care  Feb 2020 
 - 45-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1618-7601 
<br/><br/><label>Standard No.: </label>10.1007/s10198-019-01110-w  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cost-Benefit Analysis<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Markov Chains<br/>Models, Econometric<br/>Quality-Adjusted Life Years<br/>Severity of Illness Index<br/>Spondylitis, Ankylosing--drug therapy<br/>Tumor Necrosis Factor Inhibitors--administration & dosage<br/>United Kingdom<br/>Assessment of Medication Adherence